Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-TC4352 |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Mononuclear Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Peripheral Blood |
Disease | Kidney Cancer |
Storage | Liquid Nitrogen |
Product Type | Diseased Human Peripheral Blood Mononuclear Cells |
Human Kidney Cancer Peripheral Blood Mononuclear Cells are a population of mononuclear cells isolated from the peripheral blood of patients with renal cancer, mainly including lymphocytes (T cells, B cells, NK cells) and monocytes. PBMCs play a core role in immune response: T cells mediate cellular immunity, B cells produce antibodies, NK cells perform natural killing functions, and monocytes can differentiate into macrophages or dendritic cells to participate in antigen presentation. In renal cancer, the composition and function of PBMCs are often abnormal, such as an increase in the proportion of regulatory T cells (Treg) or inhibition of effector T cell function, leading to tumor immune escape.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human Kidney Cancer Peripheral Blood Mononuclear Cells can serve as a key model for studying the immune microenvironment of renal cancer and help to analyze tumor-related immunosuppression mechanisms, such as the expansion of regulatory T cells (Tregs), T cell exhaustion, or activation of myeloid-derived suppressor cells (MDSCs). PBMCs can also be used to evaluate the efficacy of immunotherapies, such as PD-1/PD-L1 inhibitors, CAR-T therapy.